Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Heart Failure with Preserved Ejection Fraction (HFpEF)
100%
Lipidome
100%
Platelets
100%
Therapeutic Potential
100%
Acetyl-CoA Carboxylase 1 (ACC1)
33%
Platelet Activation
16%
Heart Failure
16%
Endothelial Dysfunction
16%
Plasma Lipidome
8%
Preserved Ejection Fraction
8%
Vascular Endothelial Dysfunction
8%
Anti-heart Failure
8%
Fatty Acyl Chains
8%
Endothelial Factors
8%
Structural Impairment
8%
Reduced Ejection Fraction
8%
Platelet Release
8%
Platelet Factors
8%
Heart Failure Patients
8%
Lipid Content
8%
Left Ventricular Remodeling
8%
Acute Coronary Syndrome
8%
Inflammatory State
8%
Glycerophospholipids
8%
Platelet-rich Plasma
8%
Clinical Outcomes
8%
Novel Therapeutics
8%
Activated Platelets
8%
Functional Impairment
8%
Therapeutic Strategies
8%
Adult Population
8%
Clinical Syndromes
8%
Systemic Inflammation
8%
Comorbidity
8%
Monocyte Activation
8%
Fatty
8%
Plasma Membrane
8%
Circulating Levels
8%
Phospholipids
8%
Causal Role
8%
Potential Biomarkers
8%
New Subject
8%
Novel Diagnostics
8%
Clinical Cohort
8%
Interstitial Fibrosis
8%
Inflammatory Factors
8%
Diabetes
8%
Patients with Heart Failure
8%
Left Ventricular Ejection Fraction
8%
Monocyte Recruitment
8%
Current Guidelines
8%
Vascular Inflammation
8%
Plasma Samples
8%
Leukocytes
8%
Transgenic Mice
8%
Cardiovascular Risk Factors
8%
Medicine and Dentistry
Heart Failure with Preserved Ejection Fraction
100%
Lipidome
100%
Platelet
100%
Acetyl Coenzyme A Carboxylase
28%
Congestive Heart Failure
21%
Pathophysiology
21%
Thrombocyte Activation
21%
Biological Marker
14%
Endothelial Dysfunction
14%
Cardiovascular Risk
7%
Cell Membrane
7%
Physical Disease by Body Function
7%
Functional Disease
7%
Thrombocyte Release Reaction
7%
Lipid
7%
Glycerophospholipid
7%
Prevalence
7%
Comorbidity
7%
Inflammation
7%
Transgenic Mouse
7%
Clinical Syndrome
7%
Vasculitis
7%
Idiopathic Pulmonary Fibrosis
7%
Heart Failure with Reduced Ejection Fraction
7%
Mediator
7%
Leukocyte
7%
Phospholipid
7%
Monocyte
7%
Heart Ventricle Remodeling
7%
Heart Left Ventricle Ejection Fraction
7%
Disability
7%
Enzyme
7%
Ejection Fraction
7%
Cytokine
7%
Diabetes
7%
Acute Coronary Syndrome
7%
INIS
patients
100%
heart failure
100%
inflammation
35%
carboxylase
28%
control
21%
plasma
21%
hypothesis
14%
levels
14%
biological markers
14%
therapy
7%
membranes
7%
data
7%
cytokines
7%
enzymes
7%
leucocytes
7%
fibrosis
7%
coronaries
7%
contraction
7%
phospholipids
7%
transgenic mice
7%
monocytes
7%
symptoms
7%
lipids
7%
chains
7%
adults
7%
assessments
7%
interstitials
7%
mice
7%
populations
7%
risks
7%
guidelines
7%